细胞和基因供应链服务市场－全球产业规模、份额、趋势、机会和预测，按技术、应用、最终用户地区和竞争格局划分，2020-2030年预测

2024年全球细胞和基因供应链服务市场规模为14.4亿美元，预计2030年将以9.85%的复合年增长率成长至25.3亿美元。该市场涵盖运输敏感细胞和基因疗法所需的专业物流、处理和受控存储，确保从患者样本采集到给药的整个过程中产品的完整性。市场成长的主要驱动力是越来越多的此类先进疗法进入临床试验并获得监管部门批准，以及生物製药创新领域的大量投资。

主要市场驱动因素

细胞和基因治疗技术的进步显着影响供应链服务市场，带来了新的物流复杂性。基因编辑工具和先进递送系统的演进使得精准的基因修饰和更广泛的治疗应用成为可能，这需要高度专业的冷链管理和运输。

主要市场挑战

建立和维护稳健的全球一体化低温物流基础设施的复杂要求，对全球细胞和基因供应链服务市场构成了重大障碍。这些先进疗法需要超低温储存和精确、不间断的温控运输，以确保从患者样本采集到最终给药的整个过程中产品的完整性。

主要市场趋势

增强型数位化追溯和供应链优化着重于利用先进技术，实现整个供应链的即时可视性和控制。鑑于细胞和基因疗法的个人化和时效性，从患者样本采集到给药的整个过程中，对物料进行精确追踪对于维护产品完整性和患者安全至关重要。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球细胞与基因供应链服务市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按技术（云端部署、本地部署）
  • 依应用领域（订购及安排、样本采集、物流、治疗后追踪）
  • 依最终使用者分类（生物样本库/细胞库、医院、研究机构、细胞治疗实验室、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美细胞与基因供应链服务市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲细胞与基因供应链服务市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区细胞与基因供应链服务市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲细胞与基因供应链服务市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美细胞与基因供应链服务市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球细胞与基因供应链服务市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Biocair International Limited
• Arvato SE
• Associated Couriers, LLC.
• TrakCel Limited
• Parkoursc Inc.
• DHL
• McKesson Corporation
• Almac Group Limited
• Catalent Inc.
• Biostor Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Cell and Gene Supply Chain Services Market , valued at USD 1.44 Billion in 2024, is projected to experience a CAGR of 9.85% to reach USD 2.53 Billion by 2030. The Global Cell and Gene Supply Chain Services Market involves the specialized logistics, handling, and controlled storage necessary for transporting sensitive cell and gene therapies, ensuring product integrity from patient sample collection through to administration. The market's growth is predominantly supported by the increasing number of these advanced therapies progressing through clinical trials and receiving regulatory approvals, coupled with significant investments in biopharmaceutical innovation.

Key Market Drivers

Advancements in cell and gene therapy technologies significantly influence the supply chain services market by introducing novel logistical complexities. The evolution of gene editing tools and advanced delivery systems enables precise genetic modifications and expanded therapeutic applications, necessitating highly specialized cold chain management and transport.

Key Market Challenges

The intricate requirement for establishing and maintaining a robust, globally integrated cryogenic logistics infrastructure presents a significant impediment to the Global Cell and Gene Supply Chain Services Market. These advanced therapies demand ultra-cold storage and precise, uninterrupted temperature-controlled transportation to preserve product integrity from patient sample collection through final administration. The technical complexity and specialized equipment necessary for such rigorous cold chain management across diverse geographic regions create substantial operational hurdles for service providers.

Key Market Trends

Enhanced Digital Traceability and Supply Chain Optimization focuses on leveraging advanced technologies to achieve real-time visibility and control across the entire supply chain. Given the personalized and time-sensitive nature of cell and gene therapies, accurate tracking of materials from patient sample collection to administration is paramount for maintaining product integrity and patient safety. Digitalization and real-time tracking technologies can significantly minimize supply chain risks by enhancing product visibility throughout the value chain.

Key Market Players

• Biocair International Limited
• Arvato SE
• Associated Couriers, LLC.
• TrakCel Limited
• Parkoursc Inc.
• DHL
• McKesson Corporation
• Almac Group Limited
• Catalent Inc.
• Biostor Ltd.

Report Scope:

In this report, the Global Cell and Gene Supply Chain Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell and Gene Supply Chain Services Market , By Technology:

• Presence on cloud
• Presence on-premises

Cell and Gene Supply Chain Services Market , By Applications:

• Ordering and scheduling
• Sample collection
• Logistics
• Post treatment follow-up

Cell and Gene Supply Chain Services Market , By End-User:

• Biobank/ cell-bank
• Hospitals
• Research institutes
• Cell therapy labs
• Others

Cell and Gene Supply Chain Services Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cell and Gene Supply Chain Services Market .

Available Customizations:

Global Cell and Gene Supply Chain Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell and Gene Supply Chain Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Presence on cloud, Presence on-premises)
  • 5.2.2. By Applications (Ordering and scheduling, Sample collection, Logistics, Post treatment follow-up)
  • 5.2.3. By End-User (Biobank/ cell-bank, Hospitals, Research institutes, Cell therapy labs, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Cell and Gene Supply Chain Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Applications
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell and Gene Supply Chain Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Applications
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Cell and Gene Supply Chain Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Applications
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Cell and Gene Supply Chain Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Applications
      • 6.3.3.2.3. By End-User

7. Europe Cell and Gene Supply Chain Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Applications
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cell and Gene Supply Chain Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Applications
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Cell and Gene Supply Chain Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Applications
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Cell and Gene Supply Chain Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Applications
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Cell and Gene Supply Chain Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Applications
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Cell and Gene Supply Chain Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Applications
      • 7.3.5.2.3. By End-User

8. Asia Pacific Cell and Gene Supply Chain Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Applications
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cell and Gene Supply Chain Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Applications
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Cell and Gene Supply Chain Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Applications
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Cell and Gene Supply Chain Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Applications
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Cell and Gene Supply Chain Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Applications
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Cell and Gene Supply Chain Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Applications
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Cell and Gene Supply Chain Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Applications
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cell and Gene Supply Chain Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Applications
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Cell and Gene Supply Chain Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Applications
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Cell and Gene Supply Chain Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Applications
      • 9.3.3.2.3. By End-User

10. South America Cell and Gene Supply Chain Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Applications
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cell and Gene Supply Chain Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Applications
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Cell and Gene Supply Chain Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Applications
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Cell and Gene Supply Chain Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Applications
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cell and Gene Supply Chain Services Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Biocair International Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Arvato SE
• 15.3. Associated Couriers, LLC.
• 15.4. TrakCel Limited
• 15.5. Parkoursc Inc.
• 15.6. DHL
• 15.7. McKesson Corporation
• 15.8. Almac Group Limited
• 15.9. Catalent Inc.
• 15.10. Biostor Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer